BCL2 and B-cell non-Hodgkin lymphoma: For instance, it was shown that the polymorphism in the 3’UTR binding region of the BCL-2 gene, targeted by let-7b, in B-cell lymphoma was associated with fluorouracil resistance of hepatocellular carcinoma [39].